Literature DB >> 4185548

Depression during L-dopa treatment.

A M Wagshul, R B Daroff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4185548     DOI： 10.1016/s0140-6736(69)90285-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 3.  [Modern treatment of parkinsonism].

Authors:  W Birkmayer; E Neumayer
Journal:  Z Neurol       Date:  1972

4.  [The therapeutic effect of L-dopa].

Authors:  P Groneberg; A Struppler
Journal:  Naturwissenschaften       Date:  1972-11

Review 5.  Drug-induced depression. Incidence, avoidance and management.

Authors:  S B Patten; E J Love
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

6.  Does levodopa alter depression and psychopathology in Parkinsonism patients?

Authors:  G G Marsh; C H Markham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-12       Impact factor: 10.154
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.